Click on a filter below to refine your search. Remove a filter to broaden your search.
More than half (51.1%) of those with diabetes who used cannabis were aged more than 50 years.
The greatest rates were seen in states or territories with both adult and medical use legalization.
The findings persisted even after considering cigarette smoking, vaccination status, comorbidities and other risk factors.
Universal screening for cannabinoids was recommended before surgery; elective surgery should be postponed in some cases.
The findings were seen in real-world patients with a range of chronic health conditions.
In a survey, some patients reported less pain and better physical and social functioning after using medical cannabis.
The proportion of patient-reported qualifying conditions with substantial, conclusive evidence of therapeutic value decreased.
The findings show a dose-response relationship among US individuals 12 years and older.
A higher risk was seen for medical cannabis use and prescription opioid and tranquilizer/sedative use and misuse.
The likelihood of being at extremes of nightly sleep duration further increased with heavy cannabis use.